Igor Odintsov

12PUBLICATIONS

136CO-AUTHORS

Molecular targetsSolid tumoursMechanobiologyCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 22, 2026

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Jun 18, 2026

Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li-Fraumeni syndrome.

|May 04, 2026

Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition.

|Jan 05, 2026

Cardiac epithelioid hemangioendothelioma with WWTR1::ACTL6A fusion and atypical histology mimicking cardiac angiosarcoma.

Angie Kwok, David J Papke, Igor Odintsov

|Jun 11, 2025

Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.

Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty

|Jun 04, 2025

Genetic correlates of malignancy in TFE3-rearranged PEComa: a series of 14 cases.

David J Papke, Igor Odintsov, Navin R Mahadevan

Pageof 2

Frequent Collaborators

Edoardo Garbo

Romel Somwar

David J Papke

Marc Ladanyi

Biagio Ricciuti

Christopher A Febres-Aldana

Ryan Cheng

Morana Vojnic

Allan J W Lui

Marissa S Mattar

Frequent Collaborators

Edoardo Garbo

Romel Somwar

David J Papke

Marc Ladanyi